Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients?

Nijs J, Loggia ML, Polli A, Moens M, Huysmans E, Goudman L, Meeus M, Vanderweeën L, Ickmans K, Clauw D.

Expert Opin Ther Targets. 2017 Aug;21(8):817-826. doi: 10.1080/14728222.2017.1353603. Epub 2017 Jul 12. Review.

PMID:
28685641
2.

The role of TRAIL in fatigue induced by repeated stress from radiotherapy.

Feng LR, Suy S, Collins SP, Saligan LN.

J Psychiatr Res. 2017 Aug;91:130-138. doi: 10.1016/j.jpsychires.2017.03.012. Epub 2017 Mar 20.

3.

Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.

Morris G, Anderson G, Maes M.

Mol Neurobiol. 2017 Nov;54(9):6806-6819. doi: 10.1007/s12035-016-0170-2. Epub 2016 Oct 20. Review.

PMID:
27766535
4.
5.

Toward a better understanding of the central consequences of intestinal inflammation.

Nyuyki KD, Pittman QJ.

Ann N Y Acad Sci. 2015 Sep;1351:149-54. doi: 10.1111/nyas.12935. Review.

PMID:
26378439
6.

The traditional drug Gongjin-Dan ameliorates chronic fatigue in a forced-stress mouse exercise model.

Hong SS, Lee JY, Lee JS, Lee HW, Kim HG, Lee SK, Park BK, Son CG.

J Ethnopharmacol. 2015 Jun 20;168:268-78. doi: 10.1016/j.jep.2015.04.001. Epub 2015 Apr 10.

PMID:
25865680
7.

The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.

Morris G, Berk M, Galecki P, Walder K, Maes M.

Mol Neurobiol. 2016 Mar;53(2):1195-219. doi: 10.1007/s12035-015-9090-9. Epub 2015 Jan 20. Review.

PMID:
25598355
8.

Cytokine polymorphisms are associated with fatigue in adults living with HIV/AIDS.

Lee KA, Gay CL, Lerdal A, Pullinger CR, Aouizerat BE.

Brain Behav Immun. 2014 Aug;40:95-103. doi: 10.1016/j.bbi.2014.02.017. Epub 2014 Mar 12.

9.

Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies - novel tool for diagnostics and patient follow-up.

Osnes LT, Nakken B, Bodolay E, Szodoray P.

Autoimmun Rev. 2013 Aug;12(10):967-71. doi: 10.1016/j.autrev.2013.02.003. Epub 2013 Mar 26. Review.

PMID:
23541481
10.

Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.

Lindqvist D, Kaufman E, Brundin L, Hall S, Surova Y, Hansson O.

PLoS One. 2012;7(10):e47387. doi: 10.1371/journal.pone.0047387. Epub 2012 Oct 17.

11.

Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.

Lampa J, Westman M, Kadetoff D, Agréus AN, Le Maître E, Gillis-Haegerstrand C, Andersson M, Khademi M, Corr M, Christianson CA, Delaney A, Yaksh TL, Kosek E, Svensson CI.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12728-33. doi: 10.1073/pnas.1118748109. Epub 2012 Jul 16.

12.

Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression.

Maes M, Ringel K, Kubera M, Berk M, Rybakowski J.

J Affect Disord. 2012 Feb;136(3):386-92. doi: 10.1016/j.jad.2011.11.016. Epub 2011 Dec 12.

PMID:
22166399
13.

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.

Erckens RJ, Mostard RL, Wijnen PA, Schouten JS, Drent M.

Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):713-20. doi: 10.1007/s00417-011-1844-0. Epub 2011 Nov 27.

14.

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.

Gniadecki R, Robertson D, Molta CT, Freundlich B, Pedersen R, Li W, Boggs R, Zbrozek AS.

J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1436-43. doi: 10.1111/j.1468-3083.2011.04308.x. Epub 2011 Oct 31.

PMID:
22035157
15.

Biochemical regulation of sleep and sleep biomarkers.

Clinton JM, Davis CJ, Zielinski MR, Jewett KA, Krueger JM.

J Clin Sleep Med. 2011 Oct 15;7(5 Suppl):S38-42. doi: 10.5664/JCSM.1360. Review.

16.

Neuronal injury in chronic CNS inflammation.

Zindler E, Zipp F.

Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Review.

PMID:
21619866
17.

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.

J Transl Med. 2011 May 28;9:81. doi: 10.1186/1479-5876-9-81.

18.

Immune defects in breast cancer patients after radiotherapy.

Standish LJ, Torkelson C, Hamill FA, Yim D, Hill-Force A, Fitzpatrick A, Olsen M, Schildt S, Sweet E, Wenner CA, Martzen MR.

J Soc Integr Oncol. 2008 Summer;6(3):110-21.

19.

Glucocorticoid sensitivity of immune cells in severely fatigued adolescent girls: a longitudinal study.

ter Wolbeek M, van Doornen LJ, Schedlowski M, Janssen OE, Kavelaars A, Heijnen CJ.

Psychoneuroendocrinology. 2008 Apr;33(3):375-85. doi: 10.1016/j.psyneuen.2007.12.005. Epub 2008 Jan 31.

PMID:
18242001
20.

Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities.

Andersen AB, Law I, Ostrowski SR, Lebech AM, Høyer-Hansen G, Højgaard L, Gerstoft J, Ullum H, Kjaer A.

Neuroimmunomodulation. 2006;13(2):69-75. Epub 2006 Aug 22.

PMID:
16926555

Supplemental Content

Loading ...
Support Center